A Novel Role for aIIbß3 in the Development of Procoagulant Platelets via Phosphatidylserine (PS) Exposure
ISEF · 2024 Biochemistry
Overview
Platelets play a vital role in hemostasis, a critical physiological response to prevent bleeding from vascular injury. Activated platelets can be divided into two distinct subpopulations: proaggregatory and procoagulant. At the site of vessel injury, proaggregatory platelets promote platelet aggregation by releasing platelet activators through outside-in signaling of activated integrin aIIbß3 and mediating platelet-platelet interactions via fibrinogen-binding to aIIbß3. Concurrently, procoagulant platelets promote thrombin and fibrin generation by exposing phosphatidylserine (PS), which facilitates interactions with coagulation factors to stabilize the platelet plug through fibrin cross-linking. Finally, aIIbß3 signaling triggers clot retraction, thus further stabilizing the thrombus. While the role of aIIbß3 has long been established in platelet aggregation and clot retraction, no studies have demonstrated its role in coagulation and procoagulant platelet development. As such, it is reasonable to hypothesize that it may also be involved in the development of procoagulant platelets via PS exposure consequently facilitating coagulation. Through iSIM microscopy and flow cytometry, the present study demonstrates that inhibiting aIIbß3 with the monoclonal antibody antagonist 28H7Fab results in delayed PS exposure, which may be attributed to the inhibition of the procoagulant subpopulation and the existence of another PS-externalizing platelet subpopulation: apoptotic platelets. Moreover, these results were exclusive to the Fab fragment (28H7Fab) and not the whole antibody (28H7) suggesting different mechanisms of action for these aIIbß3 antagonists. Collectively, these experiments demonstrate a crucial role for aIIbB3 in the PS exposure of procoagulant platelets.
Competition history
- ISEF 2024
Resources
Related projects
ISEF · 2023
Real-Time Microfluidic Evaluation of Hemostatic Properties of Procoagulant Synthetic Platelets
ISEF · 2022
Procoagulant Synthetic Platelets To Restore Hemostatic Clot Quality in Platelet Dysfunction Settings
ISEF · 2023
Development of a Short Peptide to Prevent Non-Thrombogenic Clot Formation on Hydrophobic Surfaces
ISEF · 2017
Heteromultivalent Approaches to Clot-Targeted Nanomedicine: Combination Targeting of Platelets and Fibrin
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair